These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 33775602)

  • 1. Emergence and impact of oprD mutations in Pseudomonas aeruginosa strains in cystic fibrosis.
    Sherrard LJ; Wee BA; Duplancic C; Ramsay KA; Dave KA; Ballard E; Wainwright CE; Grimwood K; Sidjabat HE; Whiley DM; Beatson SA; Kidd TJ; Bell SC
    J Cyst Fibros; 2022 Jan; 21(1):e35-e43. PubMed ID: 33775602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbapenem resistance in cystic fibrosis strains of Pseudomonas aeruginosa as a result of amino acid substitutions in porin OprD.
    Richardot C; Plésiat P; Fournier D; Monlezun L; Broutin I; Llanes C
    Int J Antimicrob Agents; 2015 May; 45(5):529-32. PubMed ID: 25735764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ISPa46, a novel insertion sequence in the oprD porin gene of an imipenem-resistant Pseudomonas aeruginosa isolate from a cystic fibrosis patient in Marseille, France.
    Diene SM; L'homme T; Bellulo S; Stremler N; Dubus JC; Mely L; Leroy S; Degand N; Rolain JM
    Int J Antimicrob Agents; 2013 Sep; 42(3):268-71. PubMed ID: 23880169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbapenem-resistant-only Pseudomonas aeruginosa infection in patients formerly infected by carbapenem-susceptible strains.
    Tsai MH; Wu TL; Su LH; Lo WL; Chen CL; Liang YH; Chiu CH
    Int J Antimicrob Agents; 2014 Dec; 44(6):541-5. PubMed ID: 25264129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbapenem resistance mechanisms in Pseudomonas aeruginosa: alterations of porin OprD and efflux proteins do not fully explain resistance patterns observed in clinical isolates.
    El Amin N; Giske CG; Jalal S; Keijser B; Kronvall G; Wretlind B
    APMIS; 2005 Mar; 113(3):187-96. PubMed ID: 15799762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced in vivo fitness of carbapenem-resistant oprD mutants of Pseudomonas aeruginosa revealed through high-throughput sequencing.
    Skurnik D; Roux D; Cattoir V; Danilchanka O; Lu X; Yoder-Himes DR; Han K; Guillard T; Jiang D; Gaultier C; Guerin F; Aschard H; Leclercq R; Mekalanos JJ; Lory S; Pier GB
    Proc Natl Acad Sci U S A; 2013 Dec; 110(51):20747-52. PubMed ID: 24248354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of carbapenem resistance in Pseudomonas aeruginosa is associated with OprD polymorphisms, particularly the amino acid substitution at codon 170.
    Shu JC; Kuo AJ; Su LH; Liu TP; Lee MH; Su IN; Wu TL
    J Antimicrob Chemother; 2017 Sep; 72(9):2489-2495. PubMed ID: 28535274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations of OprD in carbapenem-intermediate and -susceptible strains of Pseudomonas aeruginosa isolated from patients with bacteremia in a Spanish multicenter study.
    Ocampo-Sosa AA; Cabot G; Rodríguez C; Roman E; Tubau F; Macia MD; Moya B; Zamorano L; Suárez C; Peña C; Domínguez MA; Moncalián G; Oliver A; Martínez-Martínez L;
    Antimicrob Agents Chemother; 2012 Apr; 56(4):1703-13. PubMed ID: 22290967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of efflux pumps: MexAB-OprM and MexXY(-OprA), AmpC cephalosporinase and OprD porin in non-metallo-β-lactamase producing Pseudomonas aeruginosa isolated from cystic fibrosis and burn patients.
    Aghazadeh M; Hojabri Z; Mahdian R; Nahaei MR; Rahmati M; Hojabri T; Pirzadeh T; Pajand O
    Infect Genet Evol; 2014 Jun; 24():187-92. PubMed ID: 24694825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypic and genetic resistance traits of Pseudomonas aeruginosa strains infecting cystic fibrosis patients: A French cohort study.
    Courtois N; Caspar Y; Maurin M
    Int J Antimicrob Agents; 2018 Sep; 52(3):358-364. PubMed ID: 29775685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parallel Evolution of Pseudomonas aeruginosa during a Prolonged ICU-Infection Outbreak.
    Cameron DR; Pitton M; Oberhaensli S; Schlegel K; Prod'hom G; Blanc DS; Jakob SM; Que YA
    Microbiol Spectr; 2022 Dec; 10(6):e0274322. PubMed ID: 36342287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular surveillance for carbapenemase genes in carbapenem-resistant Pseudomonas aeruginosa in Australian patients with cystic fibrosis.
    Tai AS; Kidd TJ; Whiley DM; Ramsay KA; Buckley C; Bell SC;
    Pathology; 2015 Feb; 47(2):156-60. PubMed ID: 25551306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of carbapenem resistance mechanisms in Pseudomonas aeruginosa isolates among hospitalised children in Poland: Characterisation of two novel insertion sequences disrupting the oprD gene.
    Wołkowicz T; Patzer JA; Kamińska W; Gierczyński R; Dzierżanowska D
    J Glob Antimicrob Resist; 2016 Dec; 7():119-125. PubMed ID: 27750158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phylogenetic analysis of resistance to ceftazidime/avibactam, ceftolozane/tazobactam and carbapenems in piperacillin/tazobactam-resistant Pseudomonas aeruginosa from cystic fibrosis patients.
    Zamudio R; Hijazi K; Joshi C; Aitken E; Oggioni MR; Gould IM
    Int J Antimicrob Agents; 2019 Jun; 53(6):774-780. PubMed ID: 30831233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. lptG contributes to changes in membrane permeability and the emergence of multidrug hypersusceptibility in a cystic fibrosis isolate of Pseudomonas aeruginosa.
    Harrison LB; Fowler RC; Abdalhamid B; Selmecki A; Hanson ND
    Microbiologyopen; 2019 Nov; 8(11):e844. PubMed ID: 30977288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced production of OprM may promote oprD mutations and lead to imipenem resistance in Pseudomonas aeruginosa carrying an oprD-group 1A allele.
    Shu JC; Su LH; Chiu CH; Kuo AJ; Liu TP; Lee MH; Su IN; Wu TL
    Microb Drug Resist; 2015 Apr; 21(2):149-57. PubMed ID: 25386722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic determinants of antimicrobial resistance in polymyxin B resistant Pseudomonas aeruginosa isolated from airways of patients with cystic fibrosis.
    Simão FA; Almeida MM; Rosa HS; Marques EA; Leão RS
    Braz J Microbiol; 2024 Jun; 55(2):1415-1425. PubMed ID: 38619733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatal Carbapenem Resistance Development in Pseudomonas Aeruginosa Under Meropenem Monotherapy, Caused by Mutations in the OprD Outer Membrane Porin.
    Fluit AC; Rentenaar RJ; Ekkelenkamp MB; Severs TT; Mavinkurve-Groothuis AMC; Rogers MRC; Bruin MCA; Wolfs TFW
    Pediatr Infect Dis J; 2019 Apr; 38(4):398-399. PubMed ID: 30882731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interplay of efflux system, ampC, and oprD expression in carbapenem resistance of Pseudomonas aeruginosa clinical isolates.
    Quale J; Bratu S; Gupta J; Landman D
    Antimicrob Agents Chemother; 2006 May; 50(5):1633-41. PubMed ID: 16641429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inactivation of the oprD porin gene by a novel insertion sequence ISPa195 associated with large deletion in a carbapenem-resistant Pseudomonas aeruginosa clinical isolate.
    Bocharova Y; Savinova T; Shagin DA; Shelenkov AA; Mayanskiy NA; Chebotar IV
    J Glob Antimicrob Resist; 2019 Jun; 17():309-311. PubMed ID: 30684654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.